Alpine Associates Management Inc. purchased a new stake in shares of Semler Scientific Inc. (NASDAQ:SMLR – Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 95,600 shares of the company’s stock, valued at approximately $2,868,000. Alpine Associates Management Inc. owned about 0.63% of Semler Scientific at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of the business. Police & Firemen s Retirement System of New Jersey increased its position in shares of Semler Scientific by 75.5% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 1,674 shares of the company’s stock valued at $65,000 after purchasing an additional 720 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Semler Scientific by 354.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,819 shares of the company’s stock worth $70,000 after buying an additional 1,419 shares during the last quarter. AlphaQuest LLC grew its position in Semler Scientific by 446.2% during the third quarter. AlphaQuest LLC now owns 3,419 shares of the company’s stock valued at $103,000 after buying an additional 2,793 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Semler Scientific by 47.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,965 shares of the company’s stock valued at $144,000 after buying an additional 1,269 shares during the period. Finally, JPMorgan Chase & Co. increased its holdings in Semler Scientific by 23.0% during the second quarter. JPMorgan Chase & Co. now owns 4,143 shares of the company’s stock worth $160,000 after buying an additional 776 shares during the last quarter. Hedge funds and other institutional investors own 49.37% of the company’s stock.
Semler Scientific Stock Down 4.9%
SMLR opened at $20.33 on Friday. Semler Scientific Inc. has a 12 month low of $14.89 and a 12 month high of $66.50. The company has a market cap of $310.74 million, a PE ratio of 7.31 and a beta of 1.32. The company has a current ratio of 1.97, a quick ratio of 1.95 and a debt-to-equity ratio of 0.21. The company has a 50 day moving average of $19.20 and a 200 day moving average of $25.05.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a “hold (c-)” rating on shares of Semler Scientific in a research note on Monday, December 29th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $75.33.
Get Our Latest Report on Semler Scientific
Semler Scientific Company Profile
Semler Scientific, Inc, headquartered in Princeton, New Jersey, is a medical technology company specializing in the development and commercialization of non-invasive monitoring solutions for intracranial pressure. The company’s core focus is on improving patient care in neurocritical and acute care settings by providing clinicians with advanced diagnostic tools that reduce the risks associated with invasive procedures.
The company’s flagship product, the NICO Monitor, employs proprietary acoustic monitoring technology to continuously estimate intracranial pressure and compliance at the bedside.
Further Reading
- Five stocks we like better than Semler Scientific
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
